Rhomboid Intercostal Plane Block vs Local Anesthetic Infilteration for Postoperative Analgesia After Thoracoscopic Surgery

Anesthesia Clinical Trial

Official title:

Effects of Rhomboid Intercostal Plane Block for Postoperative Analgesia After Thoracoscopic Surgery Compared With Local Anesthetic Infilteration: A Randomized Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04821947
• Other study ID #: FMASU R 34/2021
• Status: Not yet recruiting
• Phase: N/A
• Start date: April 1, 2021
• Est. completion date: August 1, 2021

Study information

• Verified date: March 2021
• Source: Ain Shams University
• Contact: Heba Fouad, MD
• Phone: 01221077317
• Email: heba.toulan[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to evaluatethe effects of rhomboid intercostal block( RIB ) on postoperative pain after thoracoscopic surgery compared with local anesthetic infiltration ( LA )

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: August 1, 2021
• Est. primary completion date: July 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• ASA status I &II

Exclusion Criteria:

• Allergic constitution
• Severe cardiovascular or hepatorenal insufficiency
• Coagulation system disease
• Injection site infection
• Morbid obesity (BMI>40 kg/m2).

Related Conditions & MeSH terms

• Anesthesia

Intervention

Other:
• Rhomboid intercostal plane block or Local anesthetic infiltration of 0.25% Bupivacaine
for RIB GroupThe following structures will be identified from superficial to deep: trapezius muscle, rhomboid major muscle, intercostal muscles between ribs, pleura, and lung. The tissue plane between the rhomboid major and intercostal muscles will be identified. A 18 gauge Tuohy needle will be advanced in plane from a superomedial-to-inferolateral direction, through the trapezius and rhomboid major muscles. The skin entry point for the first injection will be the T5-T6 level just medial to the scapula. After the location is confirmed through hydrodissection of 3 ml on the upper intercostal muscles under the rhomboid major muscle, 20ml of bupivacaine (concentration 0.25%) is injected under rhomboid major muscle LA group will receive wound infiltration of VATS incision single-incision with 10mL 0.25% bupivacaine double-incision with 15 mL (10mL+5mL) 0.25% bupivacaine three-port strategy with 17 mL (10mL+5mL+2mL) 0.25% bupivacaine

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Ain Shams University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total amount of postoperative analgesic consumption	total dose of postoperative tramadol and morphine	First 24 hours postoperative
Primary	Visual Analogue Score ( VAS )	VAS will be measured at 1st, 2nd, 4th, 6th, 12th, 24th hours postoperative at rest and during cough	First 24 hours postoperative